se of marker PKM1 and PKM2 in predicting hidden malignancy, in cases of a precancerous condition called atypical endometrial hyperplasia
Not Applicable
- Conditions
- Health Condition 1: N938- Other specified abnormal uterine and vaginal bleeding
- Registration Number
- CTRI/2021/01/030352
- Lead Sponsor
- Research committee
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Cases
1.Histopathological diagnosis of atypical endometrial hyperplasia on endometrial biopsy specimen
2.Patient willing to undergo hysterectomy
3.Final diagnosis of endometrial carcinoma on hysterectomy specimen.
4.Willing to participate in the study
Controls
1.Histopathological diagnosis of atypical endometrial hyperplasia on endometrial biopsy specimen
2.Patient willing to undergo hysterectomy
3.Final diagnosis of AEH on hysterectomy specimen.
4.Willing to participate in the study
Exclusion Criteria
Cases
1.Patients not willing for hysterectomy
2.Received medical treatment before surgery
Controls
1.Patients not willing for hysterectomy
2.Patients received medical treatment before surgery
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method